JP6829898B2 - 注入可能なマクロ多孔質ハイドロゲル - Google Patents

注入可能なマクロ多孔質ハイドロゲル Download PDF

Info

Publication number
JP6829898B2
JP6829898B2 JP2018511412A JP2018511412A JP6829898B2 JP 6829898 B2 JP6829898 B2 JP 6829898B2 JP 2018511412 A JP2018511412 A JP 2018511412A JP 2018511412 A JP2018511412 A JP 2018511412A JP 6829898 B2 JP6829898 B2 JP 6829898B2
Authority
JP
Japan
Prior art keywords
peg
gel
polyethylene glycol
reagent
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018511412A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018535704A (ja
JP2018535704A5 (enExample
Inventor
ブリュギエール，ニコラス
ゼノビーワン，マーシー
Original Assignee
イーティーエッチ チューリッヒ
イーティーエッチ チューリッヒ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イーティーエッチ チューリッヒ, イーティーエッチ チューリッヒ filed Critical イーティーエッチ チューリッヒ
Publication of JP2018535704A publication Critical patent/JP2018535704A/ja
Publication of JP2018535704A5 publication Critical patent/JP2018535704A5/ja
Application granted granted Critical
Publication of JP6829898B2 publication Critical patent/JP6829898B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • C08J9/286—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum the liquid phase being a solvent for the monomers but not for the resulting macromolecular composition, i.e. macroporous or macroreticular polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/08—Polyethers derived from hydroxy compounds or from their metallic derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2371/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/02—Dextran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00—Properties
    • C08L2201/54—Aqueous solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
JP2018511412A 2015-09-09 2016-09-08 注入可能なマクロ多孔質ハイドロゲル Active JP6829898B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15184552 2015-09-09
EP15184552.6 2015-09-09
PCT/EP2016/071238 WO2017042301A1 (en) 2015-09-09 2016-09-08 Injectable macroporous hydrogels

Publications (3)

Publication Number Publication Date
JP2018535704A JP2018535704A (ja) 2018-12-06
JP2018535704A5 JP2018535704A5 (enExample) 2019-08-22
JP6829898B2 true JP6829898B2 (ja) 2021-02-17

Family

ID=54150245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018511412A Active JP6829898B2 (ja) 2015-09-09 2016-09-08 注入可能なマクロ多孔質ハイドロゲル

Country Status (19)

Country Link
US (1) US20180264176A1 (enExample)
EP (2) EP3868416B1 (enExample)
JP (1) JP6829898B2 (enExample)
CN (2) CN113372579B (enExample)
AU (1) AU2016320395B2 (enExample)
CA (1) CA2992692C (enExample)
CY (1) CY1124571T1 (enExample)
DK (2) DK3347061T3 (enExample)
ES (1) ES2883235T3 (enExample)
HR (1) HRP20211306T1 (enExample)
HU (1) HUE055937T2 (enExample)
IL (1) IL257024B (enExample)
LT (1) LT3347061T (enExample)
PL (1) PL3347061T3 (enExample)
PT (1) PT3347061T (enExample)
RS (1) RS62239B1 (enExample)
SI (1) SI3347061T1 (enExample)
SM (1) SMT202100470T1 (enExample)
WO (1) WO2017042301A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020501646A (ja) * 2016-12-13 2020-01-23 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 生体表面のコンフォーマルコーティング
US11655343B2 (en) 2016-03-24 2023-05-23 Takeda Pharmaceutical Company Limited Alginate hydrogel compositions

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011308788B2 (en) 2010-10-01 2015-05-07 Applied Medical Resources Corporation Surgical training device
JP6169088B2 (ja) 2011-10-21 2017-07-26 アプライド メディカル リソーシーズ コーポレイション 外科訓練のための模擬組織構造
AU2012358851B2 (en) 2011-12-20 2016-08-11 Applied Medical Resources Corporation Advanced surgical simulation
EP2907125B1 (en) 2012-09-26 2017-08-02 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
US10679520B2 (en) 2012-09-27 2020-06-09 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
CA3159450A1 (en) 2012-09-27 2014-04-03 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
EP3660816B1 (en) 2013-03-01 2021-10-13 Applied Medical Resources Corporation Advanced surgical simulation constructions and methods
AU2014281483B2 (en) 2013-06-18 2018-04-12 Applied Medical Resources Corporation Gallbladder model for teaching and practicing surgical procedures
EP3410421A1 (en) 2013-07-24 2018-12-05 Applied Medical Resources Corporation First entry model
US10198966B2 (en) 2013-07-24 2019-02-05 Applied Medical Resources Corporation Advanced first entry model for surgical simulation
EP3913602B1 (en) 2014-03-26 2025-08-27 Applied Medical Resources Corporation Simulated dissectible tissue
KR102665331B1 (ko) 2014-11-13 2024-05-13 어플라이드 메디컬 리소시스 코포레이션 시뮬레이션된 조직 모델들 및 방법들
KR20250033336A (ko) 2015-02-19 2025-03-07 어플라이드 메디컬 리소시스 코포레이션 시뮬레이션된 조직 구조체들 및 방법들
KR20180008417A (ko) 2015-05-14 2018-01-24 어플라이드 메디컬 리소시스 코포레이션 전기수술 트레이닝 및 시뮬레이션을 위한 합성 조직 구조체
US12512017B2 (en) 2015-05-27 2025-12-30 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
WO2016201085A1 (en) 2015-06-09 2016-12-15 Applied Medical Resources Corporation Hysterectomy model
WO2017011436A1 (en) 2015-07-16 2017-01-19 Applied Medical Resources Corporation Simulated dissectable tissue
AU2016297579B2 (en) 2015-07-22 2022-03-17 Applied Medical Resources Corporation Appendectomy model
AU2016329211A1 (en) 2015-10-02 2018-04-26 Applied Medical Resources Corporation Hysterectomy model
EP3378053B1 (en) 2015-11-20 2023-08-16 Applied Medical Resources Corporation Simulated dissectible tissue
JP6925579B2 (ja) * 2016-03-31 2021-08-25 日油株式会社 環状ベンジリデンアセタール構造を有する生分解性ヒドロゲル
AU2017291422B2 (en) 2016-06-27 2023-04-06 Applied Medical Resources Corporation Simulated abdominal wall
ES3004046T3 (en) 2017-02-14 2025-03-11 Applied Med Resources Laparoscopic training system
US10847057B2 (en) 2017-02-23 2020-11-24 Applied Medical Resources Corporation Synthetic tissue structures for electrosurgical training and simulation
WO2019048713A1 (en) * 2017-09-11 2019-03-14 Evorion Biotechnologies Gmbh SYSTEMS, METHODS AND HYDROGELS FOR CULTURE AND CELL ANALYSIS
CN108893445A (zh) * 2018-07-26 2018-11-27 南方医科大学 一种引导视网膜神经节细胞及其轴突生长延展的方法
CN109316628B (zh) * 2018-09-21 2021-04-20 广州远想生物科技有限公司 一种凝胶及其制备方法和应用
CN109731133B (zh) * 2019-02-01 2020-09-01 浙江大学 一种抗菌、抗粘附、可注射式温敏壳聚糖凝胶敷料及其制备方法
US11680107B2 (en) * 2019-03-22 2023-06-20 Taipei Medical University Hydrogel composition for drug delivery and uses thereof
CN118325079A (zh) 2019-08-28 2024-07-12 波士顿科学国际有限公司 多臂聚恶唑啉和与其相关的组合物、系统和方法
US20230051239A1 (en) * 2020-01-03 2023-02-16 Repertoire Immune Medicines, Inc. Compositions of hydrogels and methods of use thereof
JP7679939B2 (ja) * 2020-01-28 2025-05-20 国立大学法人 東京大学 再生医療用ゲル材料
US12171833B2 (en) * 2020-02-07 2024-12-24 The University Of British Columbia Mucoadhesive polymeric drug delivery compositions and methods
CN112898600B (zh) * 2021-02-07 2023-05-23 西安工业大学 一种聚多巴胺可逆粘附凝胶的分相制备方法
JP2023020949A (ja) * 2021-07-28 2023-02-09 東ソー株式会社 細胞培養用表面処理剤
EP4463193A1 (en) 2022-01-12 2024-11-20 ETH Zurich Photocurable phase-separating hydrogels
WO2023242189A1 (en) 2022-06-13 2023-12-21 Eth Zurich Collagen visualization on microfluidic device
EP4616875A1 (en) 2024-03-12 2025-09-17 Novonexile AG Semi-interpenetrating polymer networks

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1446453A1 (en) * 2001-11-07 2004-08-18 Universität Zürich Synthetic matrix for controlled cell ingrowth and tissue regeneration and endometriosis
US20070264227A1 (en) * 2001-11-07 2007-11-15 Eidgenossische Technische Hochschule Zurich Synthetic Matrix for Controlled Cell Ingrowth and Tissue Regeneration
ES2301697T3 (es) * 2001-12-18 2008-07-01 Eidgenossisch Technische Hochschule Zurich Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos.
ATE531447T1 (de) * 2003-01-17 2011-11-15 Cornell Res Foundation Inc Injizierbare hydrogel-microsphären aus wässrigem zwei-phasen-system
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
KR100699278B1 (ko) * 2005-05-12 2007-03-23 학교법인 포항공과대학교 수화젤레이터로 유용한 바이오틴-아미노산 결합체 및이로부터 제조된 수화젤
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
AU2010276574B2 (en) * 2009-07-30 2015-08-20 Carbylan Therapeutics, Inc. Modified hyaluronic acid polymer compositions and related methods
WO2011057131A1 (en) * 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
EP3620185A1 (en) * 2010-10-06 2020-03-11 President and Fellows of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
JP6178399B2 (ja) * 2012-03-16 2017-08-09 ベンデル アナリティカル ホールディング ビー．ブイ．Ｂｅｎｄｅｒ Ａｎａｌｙｔｉｃａｌ Ｈｏｌｄｉｎｇ Ｂ．Ｖ． 求核的に活性化したポリオキサゾリンに由来する架橋ポリマー及び医療製品
PT2916881T (pt) * 2012-11-07 2020-03-17 Eth Zuerich Hidrogéis de alginato sulfatado para cultura e terapia celular

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11655343B2 (en) 2016-03-24 2023-05-23 Takeda Pharmaceutical Company Limited Alginate hydrogel compositions
US12338330B2 (en) 2016-03-24 2025-06-24 Takeda Pharmaceutical Company Limited Alginate hydrogel compositions
JP2020501646A (ja) * 2016-12-13 2020-01-23 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 生体表面のコンフォーマルコーティング
JP7125398B2 (ja) 2016-12-13 2022-08-24 ミレニアム ファーマシューティカルズ， インコーポレイテッド 生体表面のコンフォーマルコーティング
US12097306B2 (en) 2016-12-13 2024-09-24 Takeda Pharmaceutical Company Limited Conformal coating of biological surfaces
US12364791B2 (en) 2016-12-13 2025-07-22 Takeda Pharmaceutical Company Limited Conformal coating of biological surfaces

Also Published As

Publication number Publication date
CA2992692A1 (en) 2017-03-16
JP2018535704A (ja) 2018-12-06
DK3347061T3 (da) 2021-08-23
IL257024A (en) 2018-03-29
LT3347061T (lt) 2021-09-10
AU2016320395A1 (en) 2018-02-22
CA2992692C (en) 2021-12-21
RS62239B1 (sr) 2021-09-30
ES2883235T3 (es) 2021-12-07
EP3868416A1 (en) 2021-08-25
SI3347061T1 (sl) 2021-11-30
PL3347061T3 (pl) 2021-11-22
CN108025110B (zh) 2021-08-20
SMT202100470T1 (it) 2021-09-14
PT3347061T (pt) 2021-08-25
EP3868416B1 (en) 2022-08-10
IL257024B (en) 2022-02-01
DK3868416T3 (da) 2022-10-31
HRP20211306T1 (hr) 2021-11-26
EP3347061A1 (en) 2018-07-18
US20180264176A1 (en) 2018-09-20
EP3347061B1 (en) 2021-05-19
CN113372579A (zh) 2021-09-10
CY1124571T1 (el) 2022-07-22
WO2017042301A1 (en) 2017-03-16
CN113372579B (zh) 2023-07-14
CN108025110A (zh) 2018-05-11
AU2016320395B2 (en) 2020-09-17
HUE055937T2 (hu) 2022-01-28

Similar Documents

Publication Publication Date Title
CN113372579B (zh) 可注射大孔水凝胶
Tang et al. Mussel-inspired injectable hydrogel and its counterpart for actuating proliferation and neuronal differentiation of retinal progenitor cells
Bhattacharya et al. Nanofibrillar cellulose hydrogel promotes three-dimensional liver cell culture
Broguiere et al. Novel enzymatically cross-linked hyaluronan hydrogels support the formation of 3D neuronal networks
Lee et al. Advanced gellan gum-based glycol chitosan hydrogel for cartilage tissue engineering biomaterial
Nikkhah et al. Gelatin‐based biomaterials for tissue engineering and stem cell bioengineering
Zhang et al. Preparation of collagen–chondroitin sulfate–hyaluronic acid hybrid hydrogel scaffolds and cell compatibility in vitro
Costa-Almeida et al. Microengineered multicomponent hydrogel fibers: combining polyelectrolyte complexation and microfluidics
Yan et al. Constructing nerve guidance conduit using dECM‐doped conductive hydrogel to promote peripheral nerve regeneration
US11998658B2 (en) Injectable porous hydrogels
Wang et al. 3D printing of reduced glutathione grafted gelatine methacrylate hydrogel scaffold promotes diabetic bone regeneration by activating PI3K/Akt signaling pathway
Gao et al. Biomimetic silk fibroin hydrogel for enhanced peripheral nerve regeneration: synergistic effects of graphene oxide and fibroblast exosome
EP2498824A2 (en) Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers
Tavakoli et al. Ultra‐fine 3D bioprinting of dynamic hyaluronic acid hydrogel for in vitro modeling
Tsai et al. Fabrication of UV-crosslinked chitosan scaffolds with conjugation of RGD peptides for bone tissue engineering
US20190160202A1 (en) Transglutaminase mediated high molecular weight hyaluronan hydrogels
WO2014133027A1 (ja) ハイドロゲル
Lee et al. Dopamine-functionalized gellan gum hydrogel as a candidate biomaterial for a retinal pigment epithelium cell delivery system
Chen et al. Hyaluronic acid-based biphasic scaffold with layer-specific induction capacity for osteochondral defect regeneration
CN104163622B (zh) 一种锂皂石生物陶瓷的制备方法及其用途
US9023341B2 (en) Amphiphilic chitosan nanogel as an injectable delivery system for stem cell therapy
Zhang et al. Enzyme‐assisted activation technique for producing versatile hydrogel microparticle scaffolds with high surface chemical reactivity
WO2023281124A1 (en) Accelerated development of functional three-dimensional tissue moduli.
Bartolomeu Alginate hydrogels as a substrate for nerve growth
Pizzolitto SVILUPPO E CARATTERIZZAZIONE DI STRUTTURE 3D E DI IDROGELI A BASE DI POLISACCARIDI NATURALI E MODIFICATI E LORO APPLICAZIONE IN CAMPO BIOMEDICO

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190712

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190712

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200803

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201215

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210108

R150 Certificate of patent or registration of utility model

Ref document number: 6829898

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250